Back to search

Ireland· IE-PA-PA1418/021/001

Azactam 1 g Powder for Solution for Injection or Infusion

A aztreonam product containing aztreonam, registered in Ireland by Athlone Pharmaceuticals Limited. The same ATC class is registered in 16 of our 19 countries.

ATC J01DF01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedAzactam 1 g Powder for Solution for I…ATCJ01DF01REGISTER NO.IE-PA-PA1418/021/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Aztreonam is registered in 16 of 19 countries.

Countries holding a registration under ATC J01DF01 (aztreonam), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Aztreonam · ATC J01DF01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aztreonam costs, country by country.

Normalised to the WHO defined daily dose (0.225 g), the median price runs from $4.80 in Spain to $107.66 in Switzerland — a ×22 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Aztreonam · price per daily dose (0.225 g)

USD · FX 28 Sept 2026

  • CH Switzerland$107.66
  • ES Spain$4.80
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Aztreonam
Manufacturer
Athlone Pharmaceuticals Limited
Country
Ireland (IE)
ATC code
J01DF01
ATC class
Aztreonam
Defined daily dose
0.225 g, Inhal
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1418/021/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for aztreonam.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aztreonam · interactions on record

40 records

  • 10 moderate
  • 30 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • Levonorgestrel and ethinylestradiolG03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aztreonam in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aztreonam products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Azactam
  • Belgium · Azactam
  • Spain · Azactam
  • Finland · Azactam
  • France · Azactam
  • United Kingdom (Northern Ireland) · Aztreonam Kent Pharma Uk, Aztreonam Kent Pharma Uk Ltd
  • Iceland · Cayston
  • Liechtenstein · Cayston
  • Luxembourg · Azactam
  • Norway · Azactam, Cayston
  • Portugal · Azactam
  • Romania · Azactam
  • Sweden · Azactam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3fc059a7-b2db-4bce-8d5c-a2dc8d823e1a
GET /v1/drugs/3fc059a7-b2db-4bce-8d5c-a2dc8d823e1a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "routes": [
    "Intramuscular use",
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01DF",
    "J01DF01"
  ],
  "strength": null,
  "pa_number": "PA1418/021/001",
  "substances": [
    "Aztreonam"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "05/03/1985",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about aztreonam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.